<DOC>
	<DOCNO>NCT00390676</DOCNO>
	<brief_summary>N-cadherin , protein involved blood vessel cell binding , increase cancer progress , surface many tumor cell . ADH-1 block N-cadherin . This study test safety effect combination ADH-1 carboplatin ADH-1 docetaxel ADH-1 capecitabine subject specific incurable , solid tumor protein biomarker call N-cadherin .</brief_summary>
	<brief_title>A Study ADH 1 Combination With Carboplatin , Docetaxel Capecitabine</brief_title>
	<detailed_description />
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Inclusion criterion : Signed write informed consent Male female patient &gt; = 18 year age solid tumor ( ) locally advanced metastatic single agent carboplatin , docetaxel capecitabine would appropriate Measurable disease Immunohistochemical evidence Ncadherin expression tumor tissue Adequate performance status organ function , evidence hematological biochemical blood test ECG Exclusion criterion : Receipt ADH1 prior clinical study Chemotherapy , radiotherapy , investigational drug within 4 week study entry History spinal cord compression , history primary brain tumor ( ) brain metastasis ( know suspect ) unless lesion completely resolve follow appropriate treatment recurrence least 6 month History tumor show clinically significant evidence active bleeding within 12 week study entry Stroke , major surgery , major tissue injury within 4 week study entry Uncontrolled congestive heart failure , coronary artery disease , life threaten arrhythmia ; myocardial infarction within 12 month ; significant electrocardiogram ( ECG ) abnormality , know hypercoagulable state</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>cancer</keyword>
	<keyword>tumor</keyword>
	<keyword>anticarcinogenic agent</keyword>
	<keyword>antineoplastic agent</keyword>
	<keyword>cadherins</keyword>
	<keyword>solid tumor</keyword>
</DOC>